Cargando…

Impact of amyloid PET in the clinical care of veterans in a tertiary memory disorders clinic

INTRODUCTION: We aimed to characterize the clinical impact of amyloid PET (APET) in a veteran population with cognitive decline by comparing differences in management between those who did and did not have an APET. METHODS: This was a retrospective observational study. Poisson regressions and logist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vives‐Rodriguez, Ana Laura, Schiloski, Kylie A., Marin, Anna, Wang, Ryan, Hajos, Gabor P., Powsner, Rachel, DeCaro, Renée, Budson, Andrew E., Turk, Katherine W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382691/ https://www.ncbi.nlm.nih.gov/pubmed/35992216 http://dx.doi.org/10.1002/trc2.12320

Ejemplares similares

Amyloid PET ordering practices in a memory disorders clinic
por: Turk, Katherine W., et al.
Publicado: (2022)

Head Injury Exposure in Veterans Presenting to Memory Disorders Clinic: An Observational Study of Clinical Characteristics and Relationship of Event-Related Potentials and Imaging Markers
por: Turk, Katherine W., et al.
Publicado: (2021)

Home-Based Electronic Cognitive Therapy in Patients With Alzheimer Disease: Feasibility Randomized Controlled Trial
por: Marin, Anna, et al.
Publicado: (2022)

The Current of Consciousness: Neural Correlates and Clinical Aspects
por: Friedman, Garrett, et al.
Publicado: (2023)

Educating students while recruiting underrepresented populations for Alzheimer’s disease research: the Student Ambassador Program
por: DeCaro, Renée, et al.
Publicado: (2022)

The Two Sides of Sensory–Cognitive Interactions: Effects of Age, Hearing Acuity, and Working Memory Span on Sentence Comprehension
por: DeCaro, Renee, et al.
Publicado: (2016)

Clinical outcomes up to 9 years after [(18)F]flutemetamol amyloid-PET in a symptomatic memory clinic population
por: Collij, Lyduine E., et al.
Publicado: (2023)

Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
por: Müller, Ebba Gløersen, et al.
Publicado: (2019)

Spatial patterns of correlation between cortical amyloid and cortical thickness in a tertiary clinical population with memory deficit
por: Pillai, Jagan A., et al.
Publicado: (2020)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

Consciousness as a Memory System
por: Budson, Andrew E., et al.
Publicado: (2022)

Essential nuclear medicine physics
por: Powsner, Rachel A, et al.
Publicado: (2007)

White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia
por: Edwards, Lauren, et al.
Publicado: (2023)

THE ASSOCIATION OF FRAILTY WITH MCI AND DEMENTIA IN A MEMORY DISORDERS CLINIC FOR OLDER VETERANS
por: Shah, Aakashi, et al.
Publicado: (2019)

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
por: de Wilde, Arno, et al.
Publicado: (2019)

Evaluating cognitive profiles of patients undergoing clinical amyloid-PET imaging
por: Loreto, Flavia, et al.
Publicado: (2021)

THE ASSOCIATION OF MORTALITY WITH DEMENTIA IN VETERANS ENROLLED IN A MEMORY DISORDERS CLINIC: THE EFFECT OF FRAILTY
por: Shah, Aakashi, et al.
Publicado: (2019)

Clinical Impact of COVID-19 on Anticoagulation Management at the William S. Middleton Memorial Veterans Hospital
por: Hecht, Hannah, et al.
Publicado: (2020)

Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging
por: Chiotis, Konstantinos, et al.
Publicado: (2015)

Essentials of nuclear medicine physics and instrumentation
por: Powsner, Rachel A, et al.
Publicado: (2013)

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease()
por: Vandenberghe, Rik, et al.
Publicado: (2013)

Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
por: Iaccarino, Leonardo, et al.
Publicado: (2019)

Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives
por: Cotta Ramusino, Matteo, et al.
Publicado: (2021)

Quantification of amyloid PET for future clinical use: a state-of-the-art review
por: Pemberton, Hugh G., et al.
Publicado: (2022)

Recent advances in understanding Alzheimer’s Disease: diagnosis and management strategies
por: Marin, Anna, et al.
Publicado: (2023)

EVALUATING THE ASSOCIATION BETWEEN SLEEP AND MEMORY IN OLDER VETERANS WITH PTSD
por: Hall, Katherine S, et al.
Publicado: (2019)

β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population
por: Rosenberg, Anna, et al.
Publicado: (2022)

Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic
por: Bucci, Marco, et al.
Publicado: (2023)

The influence of emotional narrative content on the self-reference effect in memory
por: Mukadam, Nishaat, et al.
Publicado: (2021)

Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study
por: Grober, Ellen, et al.
Publicado: (2022)

Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET
por: Kim, Si Eun, et al.
Publicado: (2020)

Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET
por: Kim, Soo-Jong, et al.
Publicado: (2022)

Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort
por: Loreto, Flavia, et al.
Publicado: (2023)

Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic Practice
por: Lee, Jun Ho, et al.
Publicado: (2018)

Politically-polarized perceptions of governmental autonomy-support impact internal motivations to comply with COVID-19 safety guidelines
por: DeCaro, Daniel A., et al.
Publicado: (2022)

Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [(18)F] flutemetamol amyloid PET study
por: Hanseeuw, Bernard J., et al.
Publicado: (2020)

Frailty, MRI, and FDG-PET Measures in an Australian Memory Clinic Cohort
por: Jordan, Nan, et al.
Publicado: (2021)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
por: Pontecorvo, Michael J., et al.
Publicado: (2017)

Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?
por: Müller, Ebba Gløersen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eq79skbkr2skacl5n379u8cj5h